Ultimaster Drug-Eluting Stent (TCD-10023)

Sirolimus-eluting stent · Terumo Europe N.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ultimaster Drug-Eluting Stent (TCD-10023), covering 2018-07-05 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study [NA]